(Q53911320)

English

Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study. (English)

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

T Kühr

1

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

W Eisterer

2

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

U Apfelbeck

3

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

W Linkesch

4

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

O Bechter

5

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

A Zabernigg

6

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

K Geissler

7

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

G Barbieri

8

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

C Duba

9

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

G Gastl

10

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

J Thaler

11

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

publication date

1 July 2000

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

Leukemia Research

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

24

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

7

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

583-587

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytogenetic Remissions in Chronic Myelogenous Leukemia Using Interferon Alpha-2a and Hydroxyurea with or without Low-Dose Cytosine Arabinoside.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined interferon alfa-2a and cytosine arabinoside as first-line treatment for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of 11 patients with chronic myelogenous leukemia with interferon-alpha-2C and low-dose cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: Results of the austrian multicenter phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic nucleosides and nucleotides. XVI. Synthesis and biological evaluations of a series of 1-beta-D-arabinofuranosylcytosine 5'-alkyl or arylphosphates

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Participation of the peroxisomal beta-oxidation system in the chain-shortening of PCA16, a metabolite of the cytosine arabinoside prodrug, YNKO1, in rat liver

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorescence in situ hybridization (FISH) on peripheral blood smears for monitoring Philadelphia chromosome-positive chronic myeloid leukemia (CML) during interferon treatment: a new strategy for remission assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2800%2900036-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0145-2126(00)00036-9

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/10867132

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53911320&oldid=1513623121"